Zura Bio Ltd
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
ZURA$1.41+13.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(Unaudited)
(In thousands, except share and per share data)
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · For the Three Months Ended · · For the Six Months Ended | ||||||||||||
| · · June 30, · · June 30, | ||||||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||||||
| Operating expenses: · · · · · · · · · | ||||||||||||
| Research and development | | $8,704 | | $5,539 | | $19,178 | | $9,132 | ||||
| General and administrative | | | 9,358 | | | 6,220 | | 18,138 | | 11,006 | ||
| Total operating expenses | | | 18,062 | | | 11,759 | | 37,316 | | 20,138 | ||
| Loss from operations | | | (18,062) | | | (11,759) | | (37,316) | | (20,138) | ||
| Other (income)/expense, net: | | | | | | | | | | | | |
| Interest income | | | (1,717) | | | (2,196) | | | (3,534) | | | (3,411) |
| Change in fair value of private placement warrants | | | — | | | 768 | | | — | | | 1,374 |
| Other income, net | | | (352) | | | (2) | | | (347) | | | (25) |
| Total other income, net | | | (2,069) | | | (1,430) | | | (3,881) | | | (2,062) |
| Loss before income taxes | | | (15,993) | | | (10,329) | | | (33,435) | | | (18,076) |
| Income tax benefit | | | — | | | — | | | — | | | — |
| Net loss | | | (15,993) | | | (10,329) | | | (33,435) | | | (18,076) |
| Accretion of redeemable noncontrolling interest to redemption value | | | — | | | (2,337) | | | — | | | (2,337) |
| Adjustment of redeemable noncontrolling interest from redemption value to carrying value | | | — | | | — | | | — | | | 7,017 |
| Net loss attributable to Class A Ordinary Shareholders of Zura | | $(15,993) | | $(12,666) | | $(33,435) | | $(13,396) | ||||
| Net loss per share attributable to Class A Ordinary Shareholders of Zura, basic and diluted | | $(0.17) | | $(0.17) | | $(0.36) | | $(0.22) | ||||
| Weighted-average Class A Ordinary Shares used in computing net loss per share attributable to Class A Ordinary Shareholders of Zura, basic and diluted | | | 94,289,954 | | | 74,947,369 | | 93,630,719 | | 60,930,956 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.